A. B. Deisseroth

3.8k total citations · 1 hit paper
79 papers, 3.1k citations indexed

About

A. B. Deisseroth is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, A. B. Deisseroth has authored 79 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 28 papers in Oncology and 27 papers in Hematology. Recurrent topics in A. B. Deisseroth's work include Acute Myeloid Leukemia Research (14 papers), Virus-based gene therapy research (13 papers) and Chronic Myeloid Leukemia Treatments (13 papers). A. B. Deisseroth is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Virus-based gene therapy research (13 papers) and Chronic Myeloid Leukemia Treatments (13 papers). A. B. Deisseroth collaborates with scholars based in United States, United Kingdom and Türkiye. A. B. Deisseroth's co-authors include Alexander L. Dounce, Simon H. Sims, Ying Cha, Keith Gottlieb, Margaret F. Romine, Pei-Qing Gao, David F. Claxton, Michael G. Rosenblum, C Meneghetti and James M. Reuben and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

A. B. Deisseroth

77 papers receiving 3.0k citations

Hit Papers

Catalase: Physical and chemical properties, mechanism of ... 1970 2026 1988 2007 1970 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Catalase: Physical and chemical properties, mechanism of catalysis, and physiological role.
    1970 579 citations A. B. Deisseroth et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. B. Deisseroth United States 29 1.2k 1.0k 858 658 450 79 3.1k
David H. Boldt United States 31 985 0.8× 792 0.8× 388 0.5× 1.1k 1.7× 536 1.2× 71 2.9k
Astrid Gruber Sweden 34 1.8k 1.5× 927 0.9× 643 0.7× 343 0.5× 230 0.5× 99 3.5k
Yair Gazitt United States 34 1.6k 1.3× 860 0.9× 1.1k 1.3× 678 1.0× 264 0.6× 110 3.1k
S. E. Salmon United States 33 1.7k 1.4× 1.9k 1.9× 833 1.0× 462 0.7× 297 0.7× 78 3.9k
Judith A. Fox United States 29 2.5k 2.1× 942 0.9× 408 0.5× 835 1.3× 435 1.0× 80 4.2k
Nobuhiko Emi Japan 37 1.8k 1.4× 943 0.9× 1.7k 2.0× 609 0.9× 611 1.4× 170 4.3k
Françis Belloc France 32 1.6k 1.4× 713 0.7× 1.3k 1.5× 485 0.7× 722 1.6× 118 3.8k
Priscilla N. Kelly Australia 19 2.5k 2.1× 1.3k 1.3× 618 0.7× 746 1.1× 394 0.9× 92 4.4k
Eleftheria Hatzimichael Greece 30 1.6k 1.3× 554 0.6× 677 0.8× 272 0.4× 565 1.3× 114 3.0k
D H Pluznik United States 25 1.5k 1.3× 723 0.7× 725 0.8× 1.3k 2.0× 261 0.6× 77 3.5k

Countries citing papers authored by A. B. Deisseroth

Since Specialization
Citations

This map shows the geographic impact of A. B. Deisseroth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. B. Deisseroth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. B. Deisseroth more than expected).

Fields of papers citing papers by A. B. Deisseroth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. B. Deisseroth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. B. Deisseroth. The network helps show where A. B. Deisseroth may publish in the future.

Co-authorship network of co-authors of A. B. Deisseroth

This figure shows the co-authorship network connecting the top 25 collaborators of A. B. Deisseroth. A scholar is included among the top collaborators of A. B. Deisseroth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. B. Deisseroth. A. B. Deisseroth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deisseroth, A. B., et al.. (2012). TAA/ecdCD40L adenoviral prime-protein boost vaccine for cancer and infectious diseases. Cancer Gene Therapy. 20(2). 65–69. 6 indexed citations
2.
3.
Tang, Yucheng, et al.. (2009). Vector prime protein boost vaccination in the setting of myeloablative-induced lymphopenia suppresses growth of leukemia and solid tumors. Bone Marrow Transplantation. 45(3). 550–557. 1 indexed citations
4.
Fu, Siqing, F. García‐Sánchez, Injae Chung, et al.. (2009). Results of retroviral and adenoviral approaches to cancer gene therapy. Stem Cells. 16(S2). 247–250. 10 indexed citations
5.
Borgström, Per, et al.. (2007). Mapping of angiogenic markers for targeting of vectors to tumor vascular endothelial cells. Cancer Gene Therapy. 14(4). 346–353. 27 indexed citations
6.
Guinn, Barbara‐ann, James S. Norris, Farzin Farzaneh, & A. B. Deisseroth. (2006). International Society for Cell and Gene Therapy of Cancer: 2005 meeting in Shenzhen, China. Cancer Gene Therapy. 14(2). 128–138. 4 indexed citations
7.
8.
Peng, Xiaohua, Jong-Ho Won, Thomas Rutherford, et al.. (2001). The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.. PubMed. 61(11). 4405–13. 50 indexed citations
9.
Burtness, Barbara, Amanda Psyrri, Elvira D’Andrea, et al.. (1999). A phase I study of paclitaxel for mobilization of peripheral blood progenitor cells. Bone Marrow Transplantation. 23(4). 311–315. 12 indexed citations
10.
Przepiorka, Donna, Paolo Anderlini, Cindy Ippoliti, et al.. (1997). Allogeneic blood stem cell transplantation in advanced hematologic cancers. Bone Marrow Transplantation. 19(5). 455–460. 66 indexed citations
11.
Ippoliti, Cindy, Donna Przepiorka, Rakesh Mehra, et al.. (1995). Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation. Urology. 46(6). 811–815. 30 indexed citations
12.
Fairman, Jeff, et al.. (1994). Development of a sensitive PCR to detect allele loss in a model hematopoietic neoplasm.. Genome Research. 4(1). 6–12. 10 indexed citations
13.
McGlave, Philip B., Paolo de Fabritiis, A. B. Deisseroth, et al.. (1994). Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups. The Lancet. 343(8911). 1486–1488. 135 indexed citations
14.
Andreeff, Michael, Saili Zhao, Doris Drach, et al.. (1993). Expression of multidrug resistance (mdr-1) and p53 genes in hematologic cell systems: Implications for biology and gene therapy. 45(2). 131–138. 4 indexed citations
15.
Rodriguez, Maria Alma, R. Ford, A Goodacre, et al.. (1991). Chromosome 17p and p53 changes in lymphoma. British Journal of Haematology. 79(4). 575–582. 27 indexed citations
16.
LeMaistre, CF, C Meneghetti, A. B. Deisseroth, et al.. (1991). Therapeutic effects of genetically engineered toxin (DAB486IL-2) in patient with chronic lymphocytic leukaemia. The Lancet. 337(8750). 1124–1125. 29 indexed citations
17.
Estey, Elihu H., K. B. McCredie, Michael J. Keating, et al.. (1990). Treatment of acute myelogenous leukemia with chemotherapy and hematopoietic growth factors. 42(3). 156–161. 2 indexed citations
18.
Deisseroth, A. B., C.v. Herst, Simon H. Sims, et al.. (1990). Future directions in molecular and genetic therapy for Leukemias and solid tumors. 42(3). 173–180.
19.
Kantarjian, Hagop M., A. B. Deisseroth, Jordan U. Gutterman, & Moshe Talpaz. (1990). Novel therapeutic approaches for chronic myelogenous leukemia. 42(3). 149–155. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David H. Boldt Breakdown of academic impact, for papers by Astrid Gruber Breakdown of academic impact, for papers by Yair Gazitt Breakdown of academic impact, for papers by S. E. Salmon Breakdown of academic impact, for papers by Judith A. Fox Breakdown of academic impact, for papers by Nobuhiko Emi Breakdown of academic impact, for papers by Françis Belloc Breakdown of academic impact, for papers by Priscilla N. Kelly Breakdown of academic impact, for papers by Eleftheria Hatzimichael Breakdown of academic impact, for papers by D H Pluznik
Rankless by CCL
2026